Overview

Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis

Status:
Completed
Trial end date:
2019-03-28
Target enrollment:
Participant gender:
Summary
To investigate if Riociguat is effective in the treatment of systemic sclerosis
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Riociguat